| ［1］ |
Sun W， Shahrajabian MH， Ma K，et al. Advances in molecular function and recombinant expression of human collagen［J］. Pharmaceuticals (Basel）， 2025， 18（3）：430. DOI： 10.3390/ph18030430.
|
| ［2］ |
Kuivaniemi H， Tromp G. Type Ⅲ collagen （COL3A1）：gene and protein structure，tissue distribution，and associated diseases［J］. Gene， 2019， 707：151-171. DOI： 10.1016/j.gene.2019.05.003.
|
| ［3］ |
Yan J， Yin S， Chen Y，et al. Expression，optimization and biological activity analysis of recombinant type Ⅲ collagen in Komagataella phaffii［J］. Int J Biol Macromol， 2025， 288：138243. DOI： 10.1016/j.ijbiomac.2024.138243.
|
| ［4］ |
Pawelec KM， Best SM， Cameron RE. Collagen：a network for regenerative medicine［J］. J Mater Chem B， 2016， 4（40）：6484-6496. DOI： 10.1039/c6tb00807k.
|
| ［5］ |
Fu C， Ma J， Liu G，et al. Development of triple-helical recombinant collagen-silver hybrid nanofibers for anti-methicillin-resistant Staphylococcus aureus （MRSA） applications［J］. Biomed Mater， 2025， 20（1）：015012. DOI： 10.1088/1748-605X/ad95d3.
|
| ［6］ |
Long L， Hu C， Liu W，et al. Injectable multifunctional hyaluronic acid/methylcellulose hydrogels for chronic wounds repairing［J］. Carbohydr Polym， 2022， 289：119456. DOI： 10.1016/j.carbpol.2022.119456.
|
| ［7］ |
Shan Y， Wang T， Lin H. Applications of recombinant type Ⅲ collagen in tissue engineering［J］. Biomed Eng Online， 2025， 24（1）：114. DOI： 10.1186/s12938-025-01447-9.
|
| ［8］ |
Yang W， Xing Z， Wang X，et al. Microenvironment-responsive collagen hydrogel with Houttuynia cordata Thunb vesicles for diabetic wound repair［J］. Int J Biol Macromol， 2025， 320（Pt 2）：145840. DOI： 10.1016/j.ijbiomac.2025.145840.
|
| ［9］ |
Ye M， Fan Y， Fu C，et al. Biocompatible recombinant type Ⅲ collagen enhancing skin repair and anti-wrinkle effects［J］. Biomater Sci， 2024， 12（23）：6114-6122. DOI： 10.1039/d4bm01284d.
|
| ［10］ |
Jin J， Li H， Chen Z，et al. Endocytosis-mediated healing：recombinant human collagen type Ⅲ chain-induced wound healing for scar-free recovery［J］. Regen Biomater， 2025， 12：rbae149. DOI： 10.1093/rb/rbae149.
|
| ［11］ |
Niculescu A， Grumezescu AM. An up-to-date review of biomaterials application in wound management［J］. Polymers (Basel)， 2022， 14（3）：421. DOI： 10.3390/polym14030421.
|
| ［12］ |
Dart A， Bhave M， Kingshott P. Antimicrobial peptide-based electrospun fibers for wound healing applications［J］. Macromol Biosci， 2019， 19（9）：e1800488. DOI： 10.1002/mabi.201800488.
|
| ［13］ |
D'Hondt S， Guillemyn B， Syx D，et al. Type Ⅲ collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model［J］. Matrix Biol， 2018， 70：72-83. DOI： 10.1016/j.matbio.2018.03.008.
|
| ［14］ |
Dong Z， Liu Q， Han X，et al. Electrospun nanofibrous membranes of recombinant human collagen type Ⅲ promote cutaneous wound healing［J］. J Mater Chem B， 2023， 11（27）：6346-6360. DOI： 10.1039/d3tb00438d.
|
| ［15］ |
Lei X， Li M， Wang C，et al. Degradable microneedle patches loaded with antibacterial gelatin nanoparticles to treat staphylococcal infection-induced chronic wounds［J］. Int J Biol Macromol， 2022， 217：55-65. DOI： 10.1016/j.ijbiomac.2022.07.021.
|
| ［16］ |
Chen Y， Zhao Y， Zhang X，et al. Recombinant human collagen type Ⅲ microgel：an advanced injectable dermal filler for rejuvenating aging skin［J］. Regen Biomater， 2025， 12：rbaf076. DOI： 10.1093/rb/rbaf076.
|
| ［17］ |
Zhang Z， Zhao X， Song Z，et al. Electrospun collagen/chitosan composite fibrous membranes for accelerating wound healing［J］. Biomed Mater， 2024， 19（5）：055024. DOI： 10.1088/1748-605X/ad6545.
|
| ［18］ |
Behere I， Ingavle G. In vitro and in vivo advancement of multifunctional electrospun nanofiber scaffolds in wound healing applications：innovative nanofiber designs，stem cell approaches，and future perspectives［J］. J Biomed Mater Res A， 2022， 110（2）：443-461. DOI： 10.1002/jbm.a.37290.
|
| ［19］ |
Zhang X， Meng Y， Gong B，et al. Electrospun nanofibers for manipulating soft tissue regeneration［J］. J Mater Chem B， 2022， 10（37）：7281-7308. DOI： 10.1039/d2tb00609j.
|
| ［20］ |
de la Mora-López DS， Madera-Santana TJ， Olivera-Castillo L，et al. Production and performance evaluation of chitosan/collagen/honey nanofibrous membranes for wound dressing applications［J］. Int J Biol Macromol， 2024， 275（Pt 2）：133809. DOI： 10.1016/j.ijbiomac.2024.133809.
|
| ［21］ |
Patel Z， Gharat SA， Al-Tabakha MM，et al. Recent advancements in electrospun nanofibers for wound healing：polymers，clinical and regulatory perspective［J］. Crit Rev Ther Drug Carrier Syst， 2022， 39（4）：83-118. DOI： 10.1615/CritRevTherDrugCarrierSyst.2022039840.
|
| ［22］ |
Yang Z， Chen H， Yang P，et al. Nano-oxygenated hydrogels for locally and permeably hypoxia relieving to heal chronic wounds［J］ . Biomaterials， 2022， 282：121401. DOI： 10.1016/j.biomaterials.2022.121401.
|
| ［23］ |
Hu C， Liu W， Long L，et al. Microenvironment-responsive multifunctional hydrogels with spatiotemporal sequential release of tailored recombinant human collagen type Ⅲ for the rapid repair of infected chronic diabetic wounds［J］ . J Mater Chem B， 2021， 9（47）：9684-9699. DOI： 10.1039/d1tb02170b.
|
| ［24］ |
Wang Y， Zhang Y， Yang Y，et al. Versatile dopamine-functionalized hyaluronic acid-recombinant human collagen hydrogel promoting diabetic wound healing via inflammation control and vascularization tissue regeneration［J］. Bioact Mater， 2024， 35：330-345. DOI： 10.1016/j.bioactmat.2024.02.010.
|
| ［25］ |
Farjah MH， Farahpour MR. Efficacy of topical platelet-rich plasma and chitosan co-administration on Candida albicans-infected partial thickness burn wound healing［J］. Burns， 2020， 46（8）：1889-1895. DOI： 10.1016/j.burns.2020.05.019.
|
| ［26］ |
Levy SB， Marshall B. Antibacterial resistance worldwide：causes，challenges and responses［J］. Nat Med， 2004， 10（Suppl 12）：S122-S129. DOI： 10.1038/nm1145.
|
| ［27］ |
Xiong L， Zhou C， Tong L，et al. Injectable hydrogels of recombinant human collagen type Ⅲ and chitosan with antibacterial and antioxidative activities for wound healing［J］ . J Mater Chem B， 2023， 11（18）：4131-4142. DOI： 10.1039/d3tb00176h.
|
| ［28］ |
Wang X， Zhao D， Li Y，et al. Collagen hydrogel with multiple antimicrobial mechanisms as anti-bacterial wound dressing［J］. Int J Biol Macromol， 2023， 232：123413. DOI： 10.1016/j.ijbiomac.2023.123413.
|
| ［29］ |
Yang Y， Ritchie AC， Everitt NM. Using type Ⅲ recombinant human collagen to construct a series of highly porous scaffolds for tissue regeneration［J］. Colloids Surf B Biointerfaces， 2021， 208：112139. DOI： 10.1016/j.colsurfb.2021.112139.
|
| ［30］ |
Xu L， Liu Y， Tang L，et al. Preparation of recombinant human collagen Ⅲ protein hydrogels with sustained release of extracellular vesicles for skin wound healing［J］. Int J Mol Sci， 2022， 23（11）：6289. DOI： 10.3390/ijms23116289.
|
| ［31］ |
Jia Y， Han Y， Zhang Y，et al. Multifunctional type Ⅲ recombinant human collagen incorporated sodium alginate hydrogel with sustained release of extra cellular vehicles for wound healing multimodal therapy in diabetic mice［J］. Regen Ther， 2024， 27：329-341. DOI： 10.1016/j.reth.2024.03.010.
|
| ［32］ |
Nuutila K， Peura M， Suomela S，et al. Recombinant human collagen Ⅲ gel for transplantation of autologous skin cells in porcine full-thickness wounds［J］. J Tissue Eng Regen Med， 2015， 9（12）：1386-1393. DOI： 10.1002/term.1691.
|
| ［33］ |
Kong W， Bao Y， Li W，et al. Collaborative enhancement of diabetic wound healing and skin regeneration by recombinant human collagen hydrogel and hADSCs［J］. Adv Healthc Mater， 2024， 13（29）：e2401012. DOI： 10.1002/adhm.202401012.
|
| ［34］ |
Huang J， Lei X， Huang Z，et al. Bioprinted gelatin-recombinant type Ⅲ collagen hydrogel promotes wound healing［J］. Int J Bioprint， 2022， 8（2）：517. DOI： 10.18063/ijb.v8i2.517.
|
| ［35］ |
Yang Y， Xu R， Wang C，et al. Recombinant human collagen-based bioinks for the 3D bioprinting of full-thickness human skin equivalent［J］. Int J Bioprint， 2022， 8（4）：611. DOI： 10.18063/ijb.v8i4.611.
|
| ［36］ |
Ben C， Liu X， Shen T，et al. A recombinant human collagen hydrogel for the treatment of partial-thickness burns：a prospective，self-controlled clinical study［J］. Burns， 2021， 47（3）：634-642. DOI： 10.1016/j.burns.2020.01.006.
|
| ［37］ |
Zhang R，Shao W，Zhang Q，et al. The efficacy of recombinant human type Ⅲ collagen in the treatment of atrophic scars and its impact on p38 MAPK signaling pathway proteins［J］. Altern Ther Health Med，2024：AT10149.
|
| ［38］ |
Arshad MS， Zahra AT， Zafar S，et al. Antibiofilm effects of macrolide loaded microneedle patches：prospects in healing infected wounds［J］. Pharm Res， 2021， 38（1）：165-177. DOI： 10.1007/s11095-021-02995-0.
|
| ［39］ |
Wang X， Zhang X， Zhao Y，et al. Recombinant human collagen microneedle patches loaded with PRP for diabetic wound treatment［J］. J Mater Chem B， 2025， 13（31）：9607-9624. DOI： 10.1039/d5tb00836k.
|
| ［40］ |
Mascharak S， Talbott HE， Januszyk M，et al. Multi-omic analysis reveals divergent molecular events in scarring and regenerative wound healing［J］. Cell Stem Cell， 2022， 29（2）：315-327. DOI： 10.1016/j.stem.2021.12.011.
|
| ［41］ |
Ren Z， Pan X， Li J，et al. G protein coupled receptor 41 regulates fibroblast activation in pulmonary fibrosis via Gα（i/o） and downstream Smad2/3 and ERK1/2 phosphorylation［J］. Pharmacol Res， 2023， 191：106754. DOI： 10.1016/j.phrs.2023.106754.
|
| ［42］ |
Zhang X， Huang Y， Luo T，et al. Advanced wound healing and scar reduction using an innovative anti-ROS polysaccharide hydrogel with recombinant human collagen type Ⅲ［J］. ACS Appl Mater Interfaces， 2024， 16（38）：50305-50320. DOI： 10.1021/acsami.4c09890.
|
| ［43］ |
Zhang T， Wang X， Wang Z，et al. Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation［J］. Biomed Pharmacother， 2020， 129：110287. DOI： 10.1016/j.biopha.2020.110287.
|
| ［44］ |
Kim SH， Oh JM， Roh H，et al. Zinc-alpha-2-glycoprotein peptide downregulates type Ⅰ and Ⅲ collagen expression via suppression of TGF-β and p-Smad 2/3 pathway in keloid fibroblasts and rat incisional model［J］. Tissue Eng Regen Med， 2024， 21（7）：1079-1092. DOI： 10.1007/s13770-024-00664-y.
|
| ［45］ |
Fakatava N， Mitarai H， Yuda A，et al. Actin alpha 2，smooth muscle，a transforming growth factor-β1-induced factor，regulates collagen production in human periodontal ligament cells via Smad2/3 pathway［J］. J Dent Sci， 2023， 18（2）：567-576. DOI： 10.1016/j.jds.2022.08.030.
|
| ［46］ |
Bai H， Zhang W， Yan X，et al. Suture-mediated delivery system reduces the incidence of uterine scarring through the TGF-β pathway［J］. J Funct Biomater， 2025， 16（2）：52. DOI： 10.3390/jfb16020052.
|
| ［47］ |
Engelholm LH， List K， Netzel-Arnett S，et al. uPARAP/Endo180 is essential for cellular uptake of collagen and promotes fibroblast collagen adhesion［J］. J Cell Biol， 2003， 160（7）：1009-1015. DOI： 10.1083/jcb.200211091.
|
| ［48］ |
Sprangers S， Behrendt N， Engelholm L，et al. Phagocytosis of collagen fibrils by fibroblasts in vivo is independent of the uPARAP/Endo180 receptor［J］. J Cell Biochem， 2017， 118（6）：1590-1595. DOI： 10.1002/jcb.25821.
|
| ［49］ |
Madsen DH， Ingvarsen S， Jürgensen HJ，et al. The non-phagocytic route of collagen uptake：a distinct degradation pathway［J］. J Biol Chem， 2011， 286（30）：26996-27010. DOI： 10.1074/jbc.M110.208033.
|
| ［50］ |
Chang J， Pickard A， Herrera JA，et al. Endocytic recycling is central to circadian collagen fibrillogenesis and disrupted in fibrosis［J］. eLife， 2025， 13：RP95842. DOI： 10.7554/eLife.95842.
|
| ［51］ |
Zhu P， Ma M， You T，et al. Optimizing prolyl hydroxylation for functional recombinant collagen in Escherichia coli［J］. Int J Biol Macromol， 2024， 282（Pt 5）：137400. DOI： 10.1016/j.ijbiomac.2024.137400.
|
| ［52］ |
Liu S， Li Y， Wang M，et al. Efficient coexpression of recombinant human fusion collagen with prolyl 4-hydroxylase from Bacillus anthracis in Escherichia coli［J］. Biotechnol Appl Biochem， 2023， 70（2）：761-772. DOI： 10.1002/bab.2396.
|
| ［53］ |
Chen X， Yi J， Liu J，et al. Enzymatic production of trans-4-hydroxy-l-proline by proline 4-hydroxylase［J］ . Microb Biotechnol， 2021， 14（2）：479-487. DOI： 10.1111/1751-7915.13616.
|
| ［54］ |
Wang N， Li Y， Han C，et al. Optimized prolyl-4-hydroxylase expression in Komagataella phaffii enables efficient triple-helix formation of recombinant human collagen［J］. Biotechnol Bioeng， 2025， 122（12）：3406-3417. DOI： 10.1002/bit.70055.
|
| ［55］ |
Myers LK， Myllyharju J， Nokelainen M，et al. Relevance of posttranslational modifications for the arthritogenicity of type Ⅱ collagen［J］. J Immunol， 2004， 172（5）：2970-2975. DOI： 10.4049/jimmunol.172.5.2970.
|